PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19435835-0	2009	Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen.	Docetaxel	123-132	thrombospondin 1	Homo sapiens	31-35	
27487140-2	2016	The underlying mechanisms by which THBS1 and TNC regulated resistance to docetaxel were further studied using functional studies.	Docetaxel	73-82	thrombospondin 1	Homo sapiens	35-40	
27407097-0	2016	TXR1 and TSP1 expression varies by the molecular subtypes of breast cancer patients who received previous docetaxel-based first-line chemotherapy.	Docetaxel	106-115	thrombospondin 1	Homo sapiens	9-13	
12473607-14	2002	Both vascular endothelial growth factor secretion and basic fibroblast growth factor expression were inhibited by docetaxel, whereas thrombospondin-1 expression was increased by docetaxel.	Docetaxel	178-187	thrombospondin 1	Homo sapiens	133-149	
27487140-10	2016	Exogenous THBS1 and TNC protected MCF-7 cells against proliferation inhibition induced by docetaxel through activating integrin beta1/mTOR pathway.	Docetaxel	90-99	thrombospondin 1	Homo sapiens	10-15	
21290245-8	2011	Docetaxel significantly increased TSP-1 expression and secretion in HUVEC cells whereas the expression and secretion of VEGF significantly decreased in BGC-823 cells.	Docetaxel	0-9	thrombospondin 1	Homo sapiens	34-39	
21290245-9	2011	LDM docetaxel significantly inhibited BGC-823 tumor growth in the absence of toxicity, which was accompanied by decreases in microvessel density (MVD) and VEGF and increases in TSP-1 gene expression in tumor tissues.	Docetaxel	4-13	thrombospondin 1	Homo sapiens	177-182	
21157449-0	2011	Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer.	Docetaxel	78-87	thrombospondin 1	Homo sapiens	31-35	
21157449-1	2011	BACKGROUND: We explored the predictive significance of BRCA1, TXR1 and TSP1 expression in non-small-cell lung cancer (NSCLC) patients treated with docetaxel in association with cisplatin or gemcitabine.	Docetaxel	147-156	thrombospondin 1	Homo sapiens	71-75